DEOXYNIVALENOL AND ZEARALENONE AS POSSIBLE ENDOCRINE-DISRUPTING CHEMICALS IN OVARIAN STEROIDOGENESIS

被引:0
|
作者
Medvedova, Marina [1 ]
Maruniakova, Nora [1 ]
Halenar, Marek [1 ]
Omelka, Radoslav [2 ]
Martiniakova, Monika [3 ]
Kolesarova, Adriana [1 ]
机构
[1] Slovak Univ Agliculture, Fac Biotechnol & Food Sci, Dept Anim Physiol, Tr A Hlinku 2, Nitra 94976, Slovakia
[2] Constantine Philosopher Univ Nitra, Fac Nat Sci, Dept Bot & Genet, Nitra 94974, Slovakia
[3] Constantine Philosopher Univ Nitra, Fac Nat Sci, Dept Zool & Anthropol, Nitra 94974, Slovakia
关键词
deoxynivalenol; zearalenone; steroidogenesis; ovary; endocrine disruptors;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
During the 20th century, there has been an increased risk from environmental by-products that may be harmful to reproductive function in humans. Therefore, as the 21th century begins, it is appropriate to evaluate future directions within the field of reproductive toxicology. Increasingly, the enzymes involved in the steroid biosynthesis pathway are being recognized as important targets for the actions of various endocrine-disrupting chemicals. Studies in vivo and in vitro focused on the ovarian and testicular function. Ovarian steroid production and subsequent local steroid-mediated signaling are critical for normal ovarian processes, including follicle growth, oocyte maturation, and ovulation. Through the use of several in vitro models, great strides were made toward characterizing the mechanisms regulating local steroid production and action in ovary. This review aims to provide a comprehensive overview of the state of knowledge regarding the mechanisms by which mycotoxins interfere with the function of steroidogenic enzymes in various tissues and organisms.
引用
收藏
页码:1477 / +
页数:15
相关论文
共 50 条
  • [31] Endocrine-Disrupting Chemicals in Cosmetics Reply
    Rubin, Courtney Blair
    Brod, Bruce A.
    JAMA DERMATOLOGY, 2020, 156 (05) : 604 - 604
  • [32] Endocrine-disrupting chemicals and skin manifestations
    Ju, Qiang
    Zouboulis, Christos C.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03): : 449 - 457
  • [33] The challenge posed by endocrine-disrupting chemicals
    Ashby, J
    Houthoff, E
    Kennedy, SJ
    Stevens, J
    Bars, R
    Jekat, FW
    Campbell, P
    VanMiller, J
    Carpanini, FM
    Randall, GLP
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (02) : 164 - 169
  • [34] Endocrine-disrupting chemicals and skin manifestations
    Qiang Ju
    Christos C. Zouboulis
    Reviews in Endocrine and Metabolic Disorders, 2016, 17 : 449 - 457
  • [35] Endocrine-Disrupting Chemicals and Disease Endpoints
    Ahn, Changhwan
    Jeung, Eui-Bae
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [36] The burden of endocrine-disrupting chemicals in the USA
    Andreas Kortenkamp
    Nature Reviews Endocrinology, 2017, 13 : 6 - 7
  • [37] Endocrine-disrupting chemicals and uterine fibroids
    Katz, Tiffany A.
    Yang, Qiwei
    Trevino, Lindsey S.
    Walker, Cheryl Lyn
    Al-Hendy, Ayman
    FERTILITY AND STERILITY, 2016, 106 (04) : 967 - 977
  • [38] Zearalenone and its metabolites as endocrine disrupting chemicals
    Metzler, M.
    Pfeiffer, E.
    Hildebrand, A. A.
    WORLD MYCOTOXIN JOURNAL, 2010, 3 (04) : 385 - 401
  • [39] ENDOCRINE DISRUPTORS The burden of endocrine-disrupting chemicals in the USA
    Kortenkamp, Andreas
    NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (01) : 6 - 7
  • [40] Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
    Diamanti-Kandarakis, Evanthia
    Bourguignon, Jean-Pierre
    Giudice, Linda C.
    Hauser, Russ
    Prins, Gail S.
    Soto, Ana M.
    Zoeller, R. Thomas
    Gore, Andrea C.
    ENDOCRINE REVIEWS, 2009, 30 (04) : 293 - 342